Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
serpin family A member 1 | 0.410 | 0.923 | 6.8E-08 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1991 | 1991 | ||||||||
|
sphingomyelin phosphodiesterase 3 | 0.659 | 0.615 | 0.59 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
transforming growth factor beta receptor 1 | 0.451 | 0.885 | 0.85 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
transforming growth factor beta receptor 2 | 0.413 | 0.846 | 0.13 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
vascular cell adhesion molecule 1 | 0.422 | 0.808 | 0.80 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
vasoactive intestinal peptide | 0.437 | 0.846 | 4.2E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
mitofusin 1 | 0.644 | 0.577 | 2.5E-10 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
calcium sensing receptor | 0.410 | 0.846 | 4.7E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
phosphodiesterase 5A | 0.513 | 0.731 | 1.1E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
hyaluronidase 2 | 0.644 | 0.577 | 0.19 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
telomerase reverse transcriptase | 0.374 | 0.846 | 0.99 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
tachykinin receptor 1 | 0.502 | 0.885 | 3.8E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
tachykinin receptor 2 | 0.700 | 0.500 | 8.8E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
RELA proto-oncogene, NF-kB subunit | 0.406 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
BCL2 like 1 | 0.493 | 0.885 | 0.94 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
bradykinin receptor B2 | 0.585 | 0.808 | 0.12 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
C-X3-C motif chemokine ligand 1 | 0.478 | 0.808 | 0.61 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
hypoxia inducible factor 3 subunit alpha | 0.682 | 0.538 | 1.5E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
solute carrier family 2 member 4 | 0.528 | 0.769 | 4.7E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
tachykinin precursor 1 | 0.424 | 0.923 | 0.75 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
inhibitor of DNA binding 1, HLH protein | 0.544 | 0.692 | 3.1E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 |